“Dose escalation with Cs-131 PB in combination with EBRT resulted in improved bRFS compared to results previously reported with I-125 and Pd-103. The shorter half-life of Cs-131 allowed for more rapid recovery from treatment morbidity and improved HRQOL.” – IsoRay Independent Study Quote

“Dose escalation with Cs-131 PB in combination with EBRT resulted in improved bRFS compared to results previously reported with I-125 and Pd-103. The shorter half-life of Cs-131 allowed for more rapid recovery from treatment morbidity and improved HRQOL.” -IsoRay Independent Study Quote
Source - November 1, 2015 - International Journal of Radiation Oncology - Volume 93, Issue 3, Supplement, 2576, Pages E231-E232 - Health-Related Quality of Life and Efficacy Outcomes of Cs-131 Brachytherapy in Combination With External Beam Radiation Therapy in Patients With Intermediate- and High-Risk Prostate Cancer
Source – November 1, 2015 – International Journal of Radiation Oncology – Volume 93, Issue 3, Supplement, 2576, Pages E231-E232 – Health-Related Quality of Life and Efficacy Outcomes of Cs-131 Brachytherapy in Combination With External Beam Radiation Therapy in Patients With Intermediate- and High-Risk Prostate Cancer
Advertisements